Domov › Rak dojke › Kalifornija › Santa Monica

Klinične študije za Rak dojke v Santa Monica, CA

28 študij za Rak dojke išče udeležence na lokacijah v Santa Monica in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Vključevanje udeležencevFaza 3

Beverly Hills Cancer Center, Beverly Hills · 6 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06982521

A Study of PHST001 in Advanced Solid Tumors

Vključevanje udeležencevFaza 1

Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06840886

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Vključevanje udeležencevFaza 2

Beverly Hills Cancer Center, Beverly Hills · 6 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06369285

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Vključevanje udeležencevFaza 1

Research Site, Santa Monica

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT05877599

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1

Kivu Trial Site, Santa Monica

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07229313

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Vključevanje udeležencev

UCLA David Geffen School of Medicine, Santa Monica

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07214532

A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer

Vključevanje udeležencevFaza 1

Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 6 mi stran

Starost 18–80 · Ženske · Posodobljeno 23. sep. 2026 · NCT07401381

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Vključevanje udeležencevFaza 3

Clinical Trial Site, Beverly Hills · 6 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07085767

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Vključevanje udeležencevFaza 1

University of California, Los Angeles (UCLA), Santa Monica

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07114601

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Vključevanje udeležencevFaza 3

UCLA Hematology/Oncology - Parkside, Santa Monica

Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Vključevanje udeležencevFaza 2

UCLA Hematology/Oncology - Parkside, Santa Monica

Starost 18 in več · Ženske · Posodobljeno 22. sep. 2026 · NCT07287098

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Vključevanje udeležencevFaza 1/2

Beverly Hills Cancer Center, Beverly Hills · 6 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06827236

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Vključevanje udeležencevFaza 3

Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07173751

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Vključevanje udeležencevFaza 3

Cedars-Sinai Cancer Beverly Hills, Beverly Hills · 6 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT06492616

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Vključevanje udeležencevFaza 1/2

Research Site, Santa Monica

Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05123482

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Vključevanje udeležencevFaza 2

UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica

Starost 18 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT06797635

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Vključevanje udeležencevFaza 3

St. John's Cancer Center, Santa Monica
UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
UCLA-Hetamtology/Oncology_S Monica, Santa Monica
in še 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06072612

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Vključevanje udeležencevFaza 3

Tower Cancer Research Foundation, Beverly Hills · 6 mi stran
Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mi stran
Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi stran

Starost 18–60 · Ženske · Posodobljeno 2. sep. 2026 · NCT05879926

A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

Vključevanje udeležencevFaza 1

Precision Next Gen Oncology & Research Center, Beverly Hills · 6 mi stran

Starost 21 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT06075810

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

Vključevanje udeležencevFaza 2

CS Cancer at Valley Oncology Medical Group, Tarzana · 11 mi stran

Starost 45 in več · Ženske · Posodobljeno 10. avg. 2026 · NCT06092892

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Vključevanje udeležencevFaza 3

University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica

Starost 18–100 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

Vključevanje udeležencevFaza 3

Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi stran

Starost 18–50 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06748222

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Vključevanje udeležencevFaza 2

University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 mi stran
Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi stran

Starost 8 in več · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT05503797